X0206 3 2018-02-07 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001698310 Maduck Sean C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 0 1 0 0 See Remarks Common Stock 10024 D Common Stock 10000 I See Footnote Common Stock 10000 I See Footnote Stock Option (Right to Buy) 2.24 2022-11-01 Common Stock 45000 D Stock Option (Right to Buy) 2.08 2023-01-30 Common Stock 20000 D Stock Option (Right to Buy) 1.92 2023-11-19 Common Stock 25000 D Stock Option (Right to Buy) 3.02 2024-02-06 Common Stock 40000 D Stock Option (Right to Buy) 2.61 2024-08-07 Common Stock 100000 D Stock Option (Right to Buy) 3.29 2025-02-18 Common Stock 250000 D Stock Option (Right to Buy) 3.88 2026-02-26 Common Stock 150000 D Stock Option (Right to Buy) 5.05 2026-05-02 Common Stock 150000 D Stock Option (Right to Buy) 8.27 2027-02-10 Common Stock 400000 D Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee. Fully exercisable. Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of August 1, 2014, so that the total number of shares subject to this option becomes fully vested and exercisable on August 1, 2018. Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 18, 2015, so that the total number of shares subject to this option becomes fully vested and exercisable on February 18, 2019. Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 26, 2016, so that the total number of shares subject to this option becomes fully vested and exercisable on February 26, 2020. Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of April 27, 2016, so that the total number of shares subject to this option becomes fully vested and exercisable on April 27, 2020. Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 10, 2017, so that the total number of shares subject to this option becomes fully vested and exercisable on February 10, 2021. Senior Vice President, Commercial /s/ Sean Maduck 2018-02-09